Literature DB >> 20158453

Structure of the prion protein and its gene: an analysis using bioinformatics and computer simulation.

Akikazu Sakudo1, Guangai Xue, Norihito Kawashita, Yasuhisa Ano, Tatsuya Takagi, Hideharu Shintani, Yasuharu Tanaka, Takashi Onodera, Kazuyoshi Ikuta.   

Abstract

Prion protein (PrP) gene encodes cellular PrP (PrPC), a glycosylphosphatidylinositol (GPI)-anchored cell membrane protein indispensable for infections of prion, which causes Creutzfeldt-Jakob disease (CJD) in humans, bovine spongiform encephalopathy (BSE) in cattle, and scrapie in sheep. Although PrPC is known to be converted into an abnormal isoform (PrPSc) upon prion infection and play an important role in prion diseases, the mechanisms involved remain unclear, partly due to the insolubility of PrPSc, which prevents experimental biochemical and biophysical analyses. Recently, with improvements in computer power and methods, computer analyses have been contributing more to prion studies. A comparison of PrP gene sequences revealed mutations and polymorphisms in the open reading frame (ORF) of the human PrP gene related to prion diseases. In contrast, little mutations or polymorphisms related to susceptibility to BSE were found in the ORF of the bovine PrP gene, though relationships between insertion/deletion (Ins/Del) polymorphisms of the PrP gene promoter and susceptibility to BSE have been found. Our results have shown that the specific protein 1 (Sp1) plays important role in the activity of PrP gene promoter, which is influenced by polymorphisms in the Sp1 binding sites. The potential structural dynamics of PrP have been simulated by computational methods such as molecular dynamics (MD) and quantum mechanics (QM). The proposed mechanisms of conversion have revealed new insights in prion diseases. In this review, we will introduce the gene structure, polymorphisms, and potential structural dynamics of PrP revealed by basic and advanced computational analyses. The possible contribution of these methods to elucidation of the pathogenicity of prion diseases and functions of PrPC is discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20158453     DOI: 10.2174/138920310790848386

Source DB:  PubMed          Journal:  Curr Protein Pept Sci        ISSN: 1389-2037            Impact factor:   3.272


  7 in total

1.  Genetic variability of the coding region for the prion protein gene (PRNP) in gayal (Bos frontalis).

Authors:  Dongmei Xi; Qing Liu; Jianhong Guo; Hongman Yu; Yuai Yang; Yiduo He; Huaming Mao; Xiao Gou; Weidong Deng
Journal:  Mol Biol Rep       Date:  2011-06-03       Impact factor: 2.316

2.  Cellular prion protein activates Caspase 3 for apoptotic defense mechanism in astrocytes.

Authors:  Caroline M S Marques; Tatiana Pedron; Bruno L Batista; Giselle Cerchiaro
Journal:  Mol Cell Biochem       Date:  2021-02-05       Impact factor: 3.396

3.  Protein structure along the order-disorder continuum.

Authors:  Charles K Fisher; Collin M Stultz
Journal:  J Am Chem Soc       Date:  2011-06-13       Impact factor: 15.419

4.  The 5' flanking region and intron1 of the bovine prion protein gene (PRNP) are responsible for negative feedback regulation of the prion protein.

Authors:  Guangai Xue; Yoko Aida; Takashi Onodera; Akikazu Sakudo
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

5.  Discriminant analysis of prion sequences for prediction of susceptibility.

Authors:  Ji-Hae Lee; Se-Eun Bae; Sunghoon Jung; Insung Ahn; Hyeon Seok Son
Journal:  Exp Mol Med       Date:  2013-10-11       Impact factor: 8.718

6.  Scrapie incidence and PRNP polymorphisms: rare small ruminant breeds of Sicily with TSE protecting genetic reservoirs.

Authors:  Maria Vitale; Sergio Migliore; Maria La Giglia; Placido Alberti; Vincenzo Di Marco Lo Presti; Jan P M Langeveld
Journal:  BMC Vet Res       Date:  2016-07-15       Impact factor: 2.741

Review 7.  Physiological Functions of the Cellular Prion Protein.

Authors:  Andrew R Castle; Andrew C Gill
Journal:  Front Mol Biosci       Date:  2017-04-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.